Coya Therapeutics, Inc. (COYA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 8.78 |
| Open | 8.95 |
| Bid | 8.80 x 200 |
| Ask | 0.00 x 0 |
| Day's range | 8.67 - 9.01 |
| 52-week range | 3.21 - 10.69 |
| Volume | |
| Avg. volume | 100,059 |
| Market cap | 126.747M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
We're Not Very Worried About Coya Therapeutics' (NASDAQ:COYA) Cash Burn Rate
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Coya Therapeutics...
- GuruFocus.com
Coya Therapeutics Inc (COYA) Reports Fiscal 2023 Financial Results and Corporate Updates
Key Financial Highlights and Strategic Collaborations Mark COYA's Year-End Summary
- GuruFocus.com
David Einhorn's Greenlight Capital Adds Coya Therapeutics to Its Portfolio
Renowned investment firm Greenlight Capital, led by David Einhorn (Trades, Portfolio), has recently expanded its investment portfolio with the acquisition of shares in Coya Therapeutics Inc (NASDAQ:COYA). On December 12, 2023, the firm added 810,959 shares to its holdings, reflecting a significant commitment to the biotechnology company.
© 2024 Yahoo. All rights reserved.